Fukuoka M - Search Results

1

[High-dose Tegafur (FT) for primary lung cancer: a phase I trial].

Matsui K, Fukuoka M, Masuda N, Kusunoki Y, Negoro S, Takada M, Ryu S, Sakai N, Takifuji S, Kudoh S, et al. Matsui K, et al. Among authors: fukuoka m. Gan To Kagaku Ryoho. 1991 Apr;18(4):593-9. Gan To Kagaku Ryoho. 1991. PMID: 2012401 Japanese.

2

The use of granulocyte colony-stimulating factor to shorten the interval between cycles of mitomycin C, vindesine, and cisplatin chemotherapy in non-small-cell lung cancer.

Takada M, Fukuoka M, Ariyoshi Y, Furuse K, Niitani H, Ota K, Motomiya M, Hasegawa K, Tominaga K, Kuriyama T, et al. Takada M, et al. Among authors: fukuoka m. Cancer Chemother Pharmacol. 1992;31(3):182-6. doi: 10.1007/BF00685545. Cancer Chemother Pharmacol. 1992. PMID: 1281446 Clinical Trial.

3

A phase II study of CPT-11, a new derivative of camptothecin, for previously untreated non-small-cell lung cancer.

Fukuoka M, Niitani H, Suzuki A, Motomiya M, Hasegawa K, Nishiwaki Y, Kuriyama T, Ariyoshi Y, Negoro S, Masuda N, et al. Fukuoka M, et al. J Clin Oncol. 1992 Jan;10(1):16-20. doi: 10.1200/JCO.1992.10.1.16. J Clin Oncol. 1992. PMID: 1309380 Clinical Trial.

4

Mitomycin C, vindesine, and cisplatin in advanced non-small-cell lung cancer. A phase II study.

Fukuoka M, Negoro S, Masuda N, Kusunoki Y, Matsui K, Ryu S, Takifuji N, Kudoh S, Takada M. Fukuoka M, et al. Am J Clin Oncol. 1992 Feb;15(1):18-22. doi: 10.1097/00000421-199202000-00004. Am J Clin Oncol. 1992. PMID: 1312768 Clinical Trial.

5

[A phase II clinical study of cis-diammine glycolato platinum, 254-S, for primary lung cancer].

Furuse K, Fukuoka M, Kurita Y, Ariyoshi Y, Niitani H, Yoneda S, Fujii M, Hasegawa K, Nishiwaki Y, Tamura M, et al. Furuse K, et al. Among authors: fukuoka m. Gan To Kagaku Ryoho. 1992 Jun;19(6):879-84. Gan To Kagaku Ryoho. 1992. PMID: 1318698 Clinical Trial. Japanese.

6

Detection of large cell component in small cell lung carcinoma by combined cytologic and histologic examinations and its clinical implication.

Fushimi H, Kukui M, Morino H, Hosono Y, Fukuoka M, Kusunoki Y, Aozasa K, Matsumoto K. Fushimi H, et al. Among authors: fukuoka m. Cancer. 1992 Aug 1;70(3):599-605. doi: 10.1002/1097-0142(19920801)70:3<599::aid-cncr2820700310>3.0.co;2-9. Cancer. 1992. PMID: 1320448

7

[A randomized comparative study of 254-S plus vindesine (VDS) vs. cisplatin (CDDP) plus VDS in patients with advanced non-small cell lung cancer (NSCLC)].

Furuse K, Fukuoka M, Asamoto H, Niitani H, Kimura I, Sakuma A, Yamaguchi Y. Furuse K, et al. Among authors: fukuoka m. Gan To Kagaku Ryoho. 1992 Jul;19(7):1019-26. Gan To Kagaku Ryoho. 1992. PMID: 1320846 Clinical Trial. Japanese.

8

CPT-11: a new derivative of camptothecin for the treatment of refractory or relapsed small-cell lung cancer.

Masuda N, Fukuoka M, Kusunoki Y, Matsui K, Takifuji N, Kudoh S, Negoro S, Nishioka M, Nakagawa K, Takada M. Masuda N, et al. Among authors: fukuoka m. J Clin Oncol. 1992 Aug;10(8):1225-9. doi: 10.1200/JCO.1992.10.8.1225. J Clin Oncol. 1992. PMID: 1321891 Clinical Trial.

9

CPT-11 in combination with cisplatin for advanced non-small-cell lung cancer.

Masuda N, Fukuoka M, Takada M, Kusunoki Y, Negoro S, Matsui K, Kudoh S, Takifuji N, Nakagawa K, Kishimoto S. Masuda N, et al. Among authors: fukuoka m. J Clin Oncol. 1992 Nov;10(11):1775-80. doi: 10.1200/JCO.1992.10.11.1775. J Clin Oncol. 1992. PMID: 1328551

10

[New antitumor antimetabolites--gemcitabine and DMDC].

Matsui K, Fukuoka M. Matsui K, et al. Among authors: fukuoka m. Gan To Kagaku Ryoho. 1992 Nov;19(13):2127-32. Gan To Kagaku Ryoho. 1992. PMID: 1332622 Review. Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

857 results

Search Page

Filters